AbbVie 2019 revenue forecast tops Wall Street estimates while it eyes future Botox sales
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
Mizuho Securities Reiterates Buy Rating on Evolus (EOLS) Following 3Q Beat
November 5, 2019 7:22 AM ESTMizuho Securities analyst Difei Yang reiterated a Buy rating and $30.00 price target on Evolus (NASDAQ: EOLS) following the company's 3Q earnings report. Both revenue and EPS came in above consensus estimates, driven by strong sales from Jeuveau in the... More
Evolus (EOLS) Tops Q3 EPS by 15c, Revenues Beat
November 4, 2019 7:09 AM ESTEvolus (NASDAQ: EOLS) reported Q3 EPS of ($0.98), $0.15 better than the analyst estimate of ($1.13). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $4.05 million.
This was an exceptional quarter for the company on many fronts, in the U.S. and internationally,... More
